| 000 | 02484 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250516152515.0 | ||
| 264 | 0 | _c20140124 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.12246 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Zhen | |
| 245 | 0 | 0 |
_aThe hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cAug 2013 |
||
| 300 |
_a1795-809 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xmetabolism |
| 650 | 0 | 4 | _aApolipoproteins E |
| 650 | 0 | 4 |
_aAtherosclerosis _xchemically induced |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCholesterol _xmetabolism |
| 650 | 0 | 4 | _aDiet, High-Fat |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFoam Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aI-kappa B Proteins |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aScavenger Receptors, Class E _xdrug effects |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xmetabolism |
| 700 | 1 | _aHan, Yi | |
| 700 | 1 | _aLi, Ling | |
| 700 | 1 | _aLu, Hui | |
| 700 | 1 | _aMeng, Guoliang | |
| 700 | 1 | _aLi, Xiaozhen | |
| 700 | 1 | _aShirhan, Mohammed | |
| 700 | 1 | _aPeh, Meng Teng | |
| 700 | 1 | _aXie, Liping | |
| 700 | 1 | _aZhou, Suming | |
| 700 | 1 | _aWang, Xiaowei | |
| 700 | 1 | _aChen, Qi | |
| 700 | 1 | _aDai, Weilu | |
| 700 | 1 | _aTan, Choon-Hong | |
| 700 | 1 | _aPan, Shiyang | |
| 700 | 1 | _aMoore, Philip K | |
| 700 | 1 | _aJi, Yong | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 169 _gno. 8 _gp. 1795-809 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.12246 _zAvailable from publisher's website |
| 999 |
_c22786353 _d22786353 |
||